Tag Archives: vismodegib

Roche’s new medicine Erivedge received conditional EU approval for treatment of people with disfiguring and potentially life-threatening form of skin cancer

Erivedge is a new medicine that helps people with a disfiguring and potentially life-threatening form of skin cancer 19-7-2013 — /europawire.eu/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has granted conditional approval to Erivedge (vismodegib) … Read the full press release